A third vaccine dose may increase protection from omicron

The mRNA vaccines used against COVID were never designed to battle the omicron variant, a now dominant strain of the coronavirus that recently claimed 18,000 lives in a single week. Yet individuals who receive their third ...


Challenge study shows efficacy of RSV vaccine in healthy adults

For healthy adults, the bivalent prefusion F respiratory syncytial virus (RSVpreF) vaccine is effective against symptomatic RSV infection and viral shedding, according to a study published in the June 23 issue of the New ...


Rwanda breaks ground on first mRNA vaccine plant

Rwanda and German pharma company BioNTech broke ground Thursday on Africa's first mRNA vaccine factory where cutting-edge treatments for diseases like COVID-19 will be made for millions across the continent.


EU watchdog approves Valneva anti-COVID jab

The EU's medicines watchdog on Thursday approved Valneva's anti-COVID jab, Europe's sixth green-lit coronavirus vaccine, which uses more traditional technology than others on the market which the firm hopes will reduce jab ...

Diseases, Conditions, Syndromes

Monkeypox vaccine maker Bavarian Nordic ready to meet demand

As the lone laboratory manufacturing a licensed vaccine against monkeypox, Danish company Bavarian Nordic has seen its order book fill up as the usually rare disease spreads around the world.

page 2 from 631